Project Summary
Artificial Intelligence (AI) applications are increasingly used in the surveillance of an outbreak as well as care of patients with SARS-CoV-2 virus and those with COVID-19 disease. Applications of AI in COVID-19 can range from outbreak prediction, detecting and tracking COVID-19 cases to vaccine rollouts for COVID-19. Patient-Centered Outcomes Research Institute (PCORI) commissioned this emerging technology report in two volumes: a review of AI in clinical care and public health management of COVID-19 (Volume 1) and strategies to improve the impact of AI on health equity (Volume 2).
Review Report Vol. 1: Applications Used in the Clinical and Public Health Response to COVID-19 (Published December 2022)
This report draws from and expands upon the content of a previously published, PCORI-funded journal article about the use of AI in the clinical response to COVID-19 and includes our examination of the use of AI in the public health response to COVID-19, which has not been described elsewhere.
Review Report Vol. 2: Strategies to Improve the Impact of AI on Health Equity (Published February 2023)
This report draws from the content of a previously published PCORI-funded journal article on strategies to improve the impact of AI on health equity. It expands upon that article by including full descriptions of each of the equity-related issues raised by the use of AI in health care as well as the strategies proposed to address those issues that we identified in our review.
Issue Brief Vol. 1: Artificial Intelligence in the Clinical and Public Health Response to COVID-19 (Published December 2022)
The issue brief discusses the use of AI in the clinical response to COVID-19 and includes an examination of the use of AI in the public health response to COVID-19, which has not been described elsewhere.
Issue Brief Vol. 2: Strategies to Improve the Impact of Artificial Intelligence on Health Equity (Published February 2023)
The issue brief explores the issues AI poses for health equity and the types of strategies proposed to address these issues. It includes a review of academic papers, news articles, regulatory documents, and other sources, along with interviews with experts on how to improve the impact of AI on health equity.
| About the Emerging Technologies and Therapeutics Reports The Emerging Technologies and Therapeutics Reports provide timely summaries of evidence supporting new drugs, devices, and other healthcare technologies that are recently in use or may be available in the near term in the United States. The documents also identify gaps that need to be addressed for the technologies or therapeutics to move forward. |